Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History
Annual and quarterly earnings data from 1998 to 2025
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 25.6% | 9.3% | 5.0% |
| 2024 | 24.6% | 7.2% | 2.8% |
| 2023 | 25.3% | 7.0% | 2.6% |
| 2022 | 25.2% | 7.8% | 3.5% |
| 2021 | 27.1% | 10.5% | 5.5% |
Download Data
Export FMS earnings history in CSV or JSON format
Free sign-in required to download data
Fresenius Medical Care AG & Co. KGaA (FMS) Earnings Overview
As of March 2, 2026, Fresenius Medical Care AG & Co. KGaA (FMS) reported trailing twelve-month net income of $978M, reflecting +0.8% year-over-year growth. The company earned $1.71 per diluted share over the past four quarters, with a net profit margin of 0.0%.
Looking at the long-term picture, FMS's 5-year EPS compound annual growth rate (CAGR) stands at +5.1%, showing solid earnings momentum. The company achieved its highest annual net income of $1.98B in fiscal 2018.
Fresenius Medical Care AG & Co. KGaA maintains positive profitability with a gross margin of 0.3%, operating margin of 0.1%, and net margin of 0.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to industry peers including DVA ($747M net income, 0.1% margin), TOI (-$66M net income, -0.2% margin), CCM (-$163M net income, -0.8% margin), FMS has room to improve margins relative to the peer group. Compare FMS vs DVA →
Peer Comparison
Earnings metrics vs industry competitors
| Company | TTM Net Income | TTM EPS | Net Margin | ROE | YoY Growth | Compare |
|---|---|---|---|---|---|---|
FMSCurrent | $978M | $1.71 | 0.0% | 0.1% | +0.8% | — |
DVA | $747M | $8.48 | 0.1% | 0.5% | -0.2% | |
TOI | -$66M | $-0.07 | -0.2% | -2.1% | +0.2% | |
CCM | -$163M | $-1120.21 | -0.8% | -0.2% | -0.0% |
Historical Data
28 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $978M | +81.8% | $1.83B | $1.68 | 5.0% | 9.3% |
| 2024 | $538M | +7.8% | $1.39B | $0.92 | 2.8% | 7.2% |
| 2023 | $499M | -25.9% | $1.37B | $0.85 | 2.6% | 7.0% |
| 2022 | $673M | -30.5% | $1.51B | $0.57 | 3.5% | 7.8% |
| 2021 | $969M | -16.8% | $1.85B | $0.83 | 5.5% | 10.5% |
| 2020 | $1.16B | -2.9% | $2.30B | $1.31 | 6.5% | 12.9% |
| 2019 | $1.20B | -39.5% | $2.27B | $1.35 | 6.9% | 13.0% |
| 2018 | $1.98B | +54.8% | $3.04B | $3.23 | 12.0% | 18.4% |
| 2017 | $1.28B | +8.3% | $2.36B | $2.08 | 7.2% | 13.3% |
| 2016 | $1.18B | +25.6% | $2.51B | $1.87 | 6.9% | 14.7% |
See FMS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs FMS Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare FMS vs AGIO
See how FMS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is FMS growing earnings?
FMS EPS of $1.71 reflects slowing growth at +0.8%, below the 5-year CAGR of +5.1%. TTM net income is $978M. Expansion rate has moderated.
What are FMS's profit margins?
Fresenius Medical Care AG & Co. KGaA net margin is +0.0%, with operating margin at +0.1%. Below-average margins reflect competitive or cost pressures.
How consistent are FMS's earnings?
FMS earnings data spans 1998-2025. The current earnings trend is +0.8% YoY. Historical data enables comparison across business cycles.